Ingrid A. Binswanger, MD, MPH, MS

Senior Investigator

Ingrid BinswangerIngrid A. Binswanger, MD, MPH, MS, is a Senior Investigator at the Institute for Health Research. Dr. Binswanger's research focuses on how to reduce the medical complications of substance use, such as overdose and HIV.

Dr. Binswanger received her Master of Public Health degree from the University of Washington, Seattle and completed her medical training at the University of California, San Francisco. Her research team is working to develop innovative and patient-centered ways to prevent adverse events from opioid use. She also conducts research to reduce the morbidity and mortality of people who have criminal justice involvement.

Dr. Binswanger is a practicing physician in Chemical Dependency Treatment Services at Kaiser Permanente Colorado as well as an Associate Professor in the Division of General Internal Medicine at the University of Colorado School of Medicine where she also serves as the Director of the Primary Care Research Fellowship Program. She is also an Assistant Editor of the Addiction journal.


Selected Research

  • The Consequences of Sanctions for Mortality in Socially Marginalized Populations
    The goal of this project is to categorize and interpret multiple cause-of-death data from the National Death Index and help interpret the results in the context of other epidemiologic data on mortality
    Funder: National Institute of Child Health and Human Development
    Study End Date: 4/30/2018
  • Develop framework and analysis for inmate population
    The purpose of this work is to develop a framework by conducting outreach and engage experts in the field of correctional health and healthcare in order to refine the guiding principles and determine a final set of medical indicators, and develop a plan for future data collection.
    Funder: U.S. Department of Justice
    Study End Date: 8/15/2018
  • Improving Access to Pharmacotherapy for Opioid Use Disorder Among Justice-Involved Veterans
    To conduct qualitative interviews with justice-involved veterans, and VA justice outreach staff, criminal justice system staff, and VA and community health care providers who work with justice-involved veterans to improve access and use of pharmacotherapy for opioid use disorder
    Funder: National Institute on Drug Abuse
    Study End Date: 2/28/2019

  • Developing and Testing the Feasibility, Acceptability and Initial Efficacy of a Brief Peer-led Intervention to Improve Reproductive Health Among Women in Opioid Medication-assisted Treatment
    The objective of this study is to understand the pregnancy desires and motivations of women in opioid medication-assisted treatment and develop and assess the acceptability, feasibility and initial efficacy of a brief theory-based peer-led intervention to prevent unintended pregnancies among women in treatment.
    Funder: National Institutes of Health
    Study End Date: 5/31/2019

  • Integrating Addiction Research in Health Systems: The Addiction Research Network
    This proejct creates a research network that focuses on all aspects of addiction. The network will bring together 15 of the member health systems.
    Funder: National Institute on Drug Abuse
    Study End Date: 5/31/2020
  • The Safety and Impact of Expanded Access to Naloxone in Health Systems
    Our study will examine the impact and safety of expanded access to naloxone, an effective opioid antidote which reverses opioid overdose, for patients prescribed opioids for pain in two large and diverse health systems.
    Funder: National Institute on Drug Abuse
    Study End Date: 4/30/2021